Pilot Test of Five Weight Neutral Interventions to Improve Health Among Adults of Higher Body Weight
The Miriam Hospital · with National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) · NCT07363616
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 18+ · All sexes
- Healthy volunteers
- Accepted
- Study type
- Interventional · Not applicable
- Target enrollment
- 50
- US sites recruiting
- 1
- Study start
- December 31, 2025
- Record last updated
- January 23, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
The purpose of this research study is to pilot test five different, group based and remotely delivered programs designed to support healthy eating and regular physical activity. Each group will contain information and support for healthy eating and physical activity. Groups may also include support to 1) eat with more awareness of hunger and fullness, 2) improve how people think and feel about their bodies, and/or 3) identify ways to be physically active that are more enjoyable. Each group will include a unique combination of these components and the goal is to assess overall satisfaction and engagement with each of the programs.
Being studied: Mediterranean eating style; Physical activity; Mindful Eating; Body Appreciation; Enjoyable Exercise
Conditions: Obesity & Overweight; Cardiometabolic Risk Factors
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- 18 years and older
- BMI between 25-40 (if BMI is between 25-30 then additional cardiometabolic risk factor must be present including hypertension, high cholesterol, prediabetes or type 2 diabetes)
Exclusion Criteria
- current participation in a formal weight loss program
- current use of weight loss medication
- history of bariatric surgery
- physical condition that would limit the ability to engage in moderate intensity physical activity
- current pregnancy
- recent weight loss of 5% body weight
- condition that may interfere with ability to complete the study procedures
Recruiting US locations
Weight Control and Diabetes Research Center
Providence, RI 02903
Site contact: KayLoni Olson, PhD · 401-793-8971 · NEW_PATH@Brownhealth.org
Study contacts (from the official record)
- KayLoni Olson, PhD · 401-793-8971 · kayloni.olson@brownhealth.org
Similar studies in Rhode Island
All weight loss studies in Rhode Island →- RecruitingPhase 3
Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
Eli Lilly and Company
- Location
- Providence, RI + 36 other US sites
- Eligibility basics
- Ages 18–70
- RecruitingPhase 3
Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
Eli Lilly and Company
- Location
- Providence, RI + 34 other US sites
- Eligibility basics
- Ages 18–70
- RecruitingPhase 3
Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)
Amgen
- Location
- East Greenwich, RI + 30 other US sites
- Eligibility basics
- Ages 18–99
- RecruitingPhase 3
Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)
Amgen
- Location
- East Greenwich, RI + 69 other US sites
- Eligibility basics
- Ages 18–99